Moderna
MRNA
#1211
Rank
HK$152.27 B
Marketcap
HK$389.71
Share price
0.34%
Change (1 day)
41.17%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: HK$152.27 Billion

As of February 2026 Moderna has a market cap of HK$152.27 Billion. This makes Moderna the world's 1211th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$152.27 B60.54%
2025HK$94.85 B-20.88%
2024HK$119.88 B-59.52%
2023HK$296.14 B-45.07%
2022HK$539.16 B-32.85%
2021HK$802.96 B150.55%
2020HK$320.47 B525.11%
2019HK$51.26 B30.39%
2018HK$39.31 B

End of Day market cap according to different sources

On Feb 21st, 2026 the market cap of Moderna was reported to be:

HK$152.25 Billion
by Nasdaq info icon info icon
HK$152.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.566 T 2,898.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.457 T 1,513.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$2.386 T 1,467.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$4.41 B-97.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
HK$23.26 B-84.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$6.51 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$348.42 B 128.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$69.58 B-54.30%๐Ÿ‡บ๐Ÿ‡ธ USA